Edition:
United Kingdom

Tasly Pharmaceutical Group Co Ltd (600535.SS)

600535.SS on Shanghai Stock Exchange

33.83CNY
14 Feb 2018
Change (% chg)

¥-0.15 (-0.44%)
Prev Close
¥33.98
Open
¥33.98
Day's High
¥34.36
Day's Low
¥33.60
Volume
956,687
Avg. Vol
4,319,360
52-wk High
¥42.80
52-wk Low
¥32.41

Chart for

About

TASLY PHARMACEUTICAL GROUP CO., LTD. is a China-based company, principally engaged in the manufacture and distribution of pharmaceutical products. The Company provides traditional Chinese medicines, chemical preparations, chemical raw materials and biological drugs. The Company's products are applied in the treatment of... (more)

Overall

Beta: 0.57
Market Cap(Mil.): ¥37,978.73
Shares Outstanding(Mil.): 1,080.48
Dividend: 0.56
Yield (%): 1.59

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.60
EPS (TTM): -- -- --
ROI: -- 14.90 10.66
ROE: -- 16.41 14.30

BRIEF-Tasly Pharmaceutical Plans To Issue Up To 2.0 Billion Yuan Medium-Term Notes

* SAYS IT PLANS TO ISSUE UP TO 2.0 BILLION YUAN ($307.36 million) MEDIUM-TERM NOTES Source text in Chinese: http://bit.ly/2C6wiFx Further company coverage: ($1 = 6.5070 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

29 Dec 2017

BRIEF-Tasly Pharmaceutical's unit gets approval to issue up to 1 bln yuan asset-backed securities

* SAYS UNIT GETS APPROVAL TO ISSUE UP TO 1.0 BILLION YUAN ($151.56 million) ASSET-BACKED SECURITIES Source text in Chinese: http://bit.ly/2zBfelT Further company coverage: ($1 = 6.5979 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

29 Nov 2017

BRIEF-Tasly Pharmaceutical's 9-month net profit up 13.5 pct y/y

Oct 25 Tasly Pharmaceutical Group Co Ltd * Says 9-month net profit up 13.5 percent y/y Source text in Chinese: http://bit.ly/2z6sn9J Further company coverage: (Reporting by Hong Kong newsroom)

25 Oct 2017

Earnings vs. Estimates